Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
Completed · Phase 2
Conditions studied: Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor, Pancreatic Neoplasms
In brief
The purpose of this study was to assess the efficacy and safety of everolimus in the treatment of advanced pancreatic neuroendocrine tumor (NET) not responsive to cytotoxic chemotherapy. All patients were treated with everolimus until either tumor progression was documented using a standard criteria that measures tumor size called Response Evaluation Criteria in Solid tumors (RECIST), or until unacceptable toxicity occurred, or until the patient or investigator requested discontinuation of treatment.
Key facts
- Study ID
- NCT00363051
- Run by
- Novartis Pharmaceuticals
- People needed
- 160
- Starts
- 2006-06-01
- Expected to finish
- 2012-04-01
- Last updated by the study team
- 2013-05-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- USC Medical Center — Los Angeles, California, United States
- Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. — Los Angeles, California, United States
- UCLA Medical Center — Los Angeles, California, United States
- UCSF Comprehensive Cancer Center — San Francisco, California, United States
- University of Miami — Miami, Florida, United States
- H. Lee Moffit Cancer Center & Research Institute — Tampa, Florida, United States
- Emory University Hospital — Atlanta, Georgia, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- LSUHC Multispecialty Clinic — New Orleans, Louisiana, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire, United States
- Lynn Ratner, M.D. — New York, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Arthur G. James Cancer Hospital/Ohio State University — Columbus, Ohio, United States
- Oregon Health and Science University — Portland, Oregon, United States
- M. D Anderson Cancer Center — Houston, Texas, United States
- Scott & White Memorial Hospital — Temple, Texas, United States
- University of Wisconsin Hospital & Clinics — Madison, Wisconsin, United States
- Novartis Investigative Site — Buenos Aires, Argentina
- Novartis Investigative Site — Santa Fe, Argentina
- Novartis Investigative Site — Heidelberg, Australia
- Novartis Investigative Site — Herston, Australia
- Novartis Investigative Site — Kogarah, Australia
- The University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.